#FreeChangsha3: Wrongfully Detained HIV/Viral Hepatitis Activists

Three Chinese lawyers and advocates, Cheng Yuan, Wu Gejianxiong, and Liu Yongze, who work on employment discrimination and disability justice for people living with HIV and viral hepatitis, have been wrongfully detained in Hunan, China since 22 July 2019. More
WE NEED A COMPREHENSIVE HEPATITIS C PACKAGE OF SERVICES FOR PEOPLE WHO USE AND INJECT DRUGS! “It’s been more than 5 years since we cured hepatitis C...where’s my package?”

Achieving hepatitis C virus (HCV) elimination by 2030 depends on how countries fund prevention, testing, treatment, and care and how they include HCV in efforts for universal health coverage. (...) More
Have a heart, save my liver! Where are my diagnostics?

Of the 71 million people living with chronic hepatitis C, only ≈20% are aware of their status and less than 5% of people living in LMICs have been diagnosed.
We need simpler & cheaper tests to scale up diagnosis! More
Hepatitis C cure, sofosbuvir, turns 5 years old: The vast majority of people still have not been treated

Advocates scandalized that Gilead’s hepatitis C profits have raked in US$25.8 billion, which could have treated everyone while still earning US$16 billion in profits. 6 December 2018, Paris, (...) More
Dying at these prices: Generic HCV cure denied mapCrowd report #2

To mark the significance of World Hepatitis Day, Médecins du Monde (MdM) and Treatment Action Group (TAG) have produced a new report Dying at these prices: Generic HCV cure denied, based on crowdsourced hepatitis C data from over 40 countries available at mapCrowd.org. More

Recent publications

Activist Guide to Hepatitis C Virus Diagnostics

Out Now! A NEW Activist Guide to Hepatitis C Virus (HCV) Diagnostics is to provide information for you and your community. The Activist Guide aims to provide a deeper focus on diagnosis with updated information about the steps and different technologies involved in diagnosing a person with (...) More
31 October 2019
Strengthening Advocacy for Hepatitis C Diagnostics: Malaysia Workshop Summary Report

1-3 March 2019, Penang, Malaysia
Positive Malaysian Treatment Access and Advocacy Group (MTAAG+), with partners Treatment Action Group and the Foundation for Innovative New Diagnostics, convened the first advocacy workshop on hepatitis C virus (HCV) diagnostics. The workshop presented the (...) More
14 June 2019
Strengthening Advocacy for Hepatitis C Diagnostics: Georgia Workshop Summary Report

13-15 May 2019, Tbilisi, Georgia
The Georgian Harm Reduction Network (GHRN), in partnership with the Foundation for Innovative New Diagnostics (FIND), Treatment Action Group (TAG), and the Georgia Community Advisory Board (GeCAB)—comprised of medical and other healthcare providers and affected (...) More
10 July 2019
Global Declaration to Eliminate Hepatitis C in People Who Use Drugs: A call for political leaders to take action

Sign the pledge! If elimination by 2030 is to be achieved, the global community needs to act immediately. More
31 October 2018
Updated Hepatitis C Treatment Guidelines

Geneva - July 2018
The World Health Organization released the updated Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection. They follow and update the screening and care section of the WHO Guidelines for the screening, care and treatment of (...) More
8 November 2018